Rapid sequence intubation is used, when there is an elevated risk of aspiration to the lungs of stomach content. It is typically used in acute settings that require acute surgery or in prehospital settings, but also in specific risk patients requiring elective surgery. The reason for conducting rapid sequence intubation is to minimize the risk of pulmonary aspiration and at the same time achieve a fast induction of anaesthesia and intubation. Rapid sequence intubation is a procedure with a high risk of complications in itself. The time period from induction of anaesthesia to intubation is particularly risky, because the patient is apneic. This study addresses this problem by investigating, how quickly spontaneous respiration can be reestablished after a rapid sequence intubation when using Rocuronium-Sugammadex compared to Succinylcholine. This is a pilot protocol that is intended to establish a sample size for the full protocol. Study hypothesis: The time from correct tube placement to spontaneous respiration is shorter when using Rocuronium/Sugammadex compared to Succinylcholine.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
61
Rocuronium 1,0 mg/kg is administered iv initially. Upon intubation Sugammadex is administered 16 mg/kg iv.
1 mg/kg
Rigshospitalet
Copenhagen, Denmark
Herlev Hospital
Herlev, Denmark
Time from verified correct tube placement after intubation to spontaneous respiration, defined as respiration frequency of >8/minute, tidal volume >3ml/kg and a saturation of >90% for 30 seconds.
Time frame: 20 minutes
Duration of action. Measured as the time from administration of the neuromuscular blocking agent to the T1-value in Train-of-Four (TOF) returns to >90% of T1-max.
Time frame: 20 minutes
Intubation Difficulty Scale (IDS)
Time frame: 20 minutes
Intubation conditions
Time frame: 20 minutes
Side effect - Muscle ache.
Time frame: Postoperative (within 24 hours)
Side effect - Tachycardia (>100 beats per minute).
Time frame: 20 minutes
Side effect - Bradycardia (<50 beats per minute).
Time frame: 20 minutes
Side effect - Awareness/recall. Evaluated by modified Brice Questionaire.
Time frame: Postoperative (within 24 hours)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.